Skip to main content

Cases compared

AstraZeneca Pharmaceuticals LP, et al., Petitioners v. Mosaic Health, Inc., et al. vs. Nexstar Media Group, Inc. v. DirecTV, LLC vs. The Hain Celestial Group, Inc., et al., Petitioners v. Salamon Gimpel, et al.

Business and Regulation cases on the Supreme Court docket, side by side.

No. 25-1070No. 25-1243No. 25-1255

Side by side

AstraZeneca Pharmaceuticals LP, et al., Petitioners v. Mosaic Health, Inc., et al. vs. Nexstar Media Group, Inc. v. DirecTV, LLC vs. The Hain Celestial Group, Inc., et al., Petitioners v. Salamon Gimpel, et al., compared fact by fact
FactAstraZeneca Pharmaceuticals LP, et al., Petitioners v. Mosaic Health, Inc., et al.Nexstar Media Group, Inc. v. DirecTV, LLCThe Hain Celestial Group, Inc., et al., Petitioners v. Salamon Gimpel, et al.
DocketAstraZeneca Pharmaceuticals LP, et al., Petitioners v. Mosaic Health, Inc., et al.25-1070Nexstar Media Group, Inc. v. DirecTV, LLC25-1243The Hain Celestial Group, Inc., et al., Petitioners v. Salamon Gimpel, et al.25-1255
StatusAstraZeneca Pharmaceuticals LP, et al., Petitioners v. Mosaic Health, Inc., et al.Before ArgumentsNexstar Media Group, Inc. v. DirecTV, LLCBefore ArgumentsThe Hain Celestial Group, Inc., et al., Petitioners v. Salamon Gimpel, et al.Before Arguments
DateAstraZeneca Pharmaceuticals LP, et al., Petitioners v. Mosaic Health, Inc., et al.October Term 2025 (2025–2026)Nexstar Media Group, Inc. v. DirecTV, LLCOctober Term 2025 (2025–2026)The Hain Celestial Group, Inc., et al., Petitioners v. Salamon Gimpel, et al.October Term 2025 (2025–2026)
Question presentedAstraZeneca Pharmaceuticals LP, et al., Petitioners v. Mosaic Health, Inc., et al.1. Whether Illinois Brick Co. v. Illinois, 431 U.S. 720 (1977), which bars antitrust claims by indirect purchasers and sellers, applies to a claim of “lost profit” damages based on indirect purchases or sales that were not made due to the alleged conspiracy? 2. Whether the allegation that businesses had an “opportunity to conspire,” such as through joint lobbying and participation in a trade association, plausibly suggests an antitrust conspiracy?Nexstar Media Group, Inc. v. DirecTV, LLCWhether a plaintiff has antitrust standing to recover purported downstream losses flowing from its decision not to purchase an allegedly price-fixed product?The Hain Celestial Group, Inc., et al., Petitioners v. Salamon Gimpel, et al.1. Whether a plaintiff may plead scienter based on the “core operations doctrine,” under which the alleged significance of an issue supports an inference that defendants must have known about it. 2. Whether a plaintiff may plead scienter by alleging that executives generally receive information through routine corporate communications, such as internal reports or customer calls, without specifying the contents of those communications.
SummaryAstraZeneca Pharmaceuticals LP, et al., Petitioners v. Mosaic Health, Inc., et al.AstraZeneca, Eli Lilly, Novo Nordisk, and Sanofi ask the Supreme Court to review a Second Circuit antitrust case brought by health-care providers. The dispute concerns whether the providers may seek lost-profit damages tied to purchases or sales they say did not occur because of an alleged drug-pricing conspiracy, and whether allegations of joint lobbying and trade-association participation plausibly show an agreement to conspire.Nexstar Media Group, Inc. v. DirecTV, LLCNexstar Media Group asks the Supreme Court to review a Second Circuit ruling that allowed DirecTV to seek antitrust damages for claimed lost downstream revenue after it chose not to buy allegedly price-fixed television programming. The case concerns whether a business that did not purchase the allegedly overpriced product can nevertheless show the direct, non-speculative injury required for antitrust standing.The Hain Celestial Group, Inc., et al., Petitioners v. Salamon Gimpel, et al.Hain Celestial asks the Supreme Court to review a securities-fraud lawsuit in which investors claim that company executives acted knowingly or recklessly in making misleading statements. The case concerns how specifically plaintiffs must allege facts showing that executives knew of, or deliberately ignored, the alleged problems under the federal securities-laws pleading standard.

Relationship

Shared issue
Business and Regulation
Why compared
Reviewed Business and Regulation tags connect these current-term public cases.

Related

Sources

  • Built from reviewed issue tags and official docket records. Status lines and questions presented come from the tracked case data.